Structure
Most formularies sort covered drugs into tiers. Lower tiers usually hold generic drugs with the lowest copays. Higher tiers hold preferred brands, non-preferred brands and specialty drugs, with higher copays or coinsurance. The tier sets what the patient pays at the pharmacy.
A formulary can also attach rules to a drug. Common rules are prior authorization, step therapy and quantity limits.
Who builds a formulary
A health plan or its pharmacy benefit manager builds the formulary, often with a committee of pharmacists and doctors that reviews clinical evidence. Price and manufacturer rebates also affect which drugs are preferred. Formularies are usually updated once a year, and some changes happen during the year.
Medicare Part D plans must follow federal rules for their formularies, including required coverage of certain drug classes. Part D formularies may not cover drugs used only for weight loss, because federal law excludes them.
Exceptions
When a needed drug is not on the formulary, the prescriber can ask the plan for a formulary exception. The request explains why covered drugs are not suitable. If the plan denies it, the patient can usually appeal.
Formularies and GLP-1 medicines
A formulary may list a GLP-1 medicine for type 2 diabetes, such as Ozempic or Mounjaro, but exclude brands approved for weight management, such as Wegovy or Zepbound. Some plans add weight-loss drugs only as an optional benefit that the employer pays extra for. Formularies can also prefer one brand over another, which may change from year to year.
From July 1, 2026 through December 31, 2027, the Medicare GLP-1 Bridge covers selected GLP-1 medicines for weight reduction outside the regular Part D formulary. People without coverage can compare programs on the without insurance page.
Compare programs without insurance
See also
References
- KFF: What to know about the BALANCE model for GLP-1s in Medicare and Medicaid and the Medicare GLP-1 Bridge (May 11, 2026). kff.org
- FTC: FTC releases interim staff report on prescription drug middlemen (July 9, 2024). ftc.gov
- CMS: Interoperability and Prior Authorization Final Rule (CMS-0057-F) fact sheet. cms.gov
Last updated . Category: Insurance & cost. Browse all 38 WikiTelehealth entries.